These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 30698677)

  • 1. The CD26/DPP4-inhibitor vildagliptin suppresses lung cancer growth via macrophage-mediated NK cell activity.
    Jang JH; Janker F; De Meester I; Arni S; Borgeaud N; Yamada Y; Gil Bazo I; Weder W; Jungraithmayr W
    Carcinogenesis; 2019 Apr; 40(2):324-334. PubMed ID: 30698677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-inflammatory effects on ischemia/reperfusion-injured lung transplants by the cluster of differentiation 26/dipeptidylpeptidase 4 (CD26/DPP4) inhibitor vildagliptin.
    Jang JH; Yamada Y; Janker F; De Meester I; Baerts L; Vliegen G; Inci I; Chatterjee S; Weder W; Jungraithmayr W
    J Thorac Cardiovasc Surg; 2017 Mar; 153(3):713-724.e4. PubMed ID: 27939504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dipeptidyl Peptidase 4 Inhibitors Reduce Hepatocellular Carcinoma by Activating Lymphocyte Chemotaxis in Mice.
    Nishina S; Yamauchi A; Kawaguchi T; Kaku K; Goto M; Sasaki K; Hara Y; Tomiyama Y; Kuribayashi F; Torimura T; Hino K
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):115-134. PubMed ID: 30510994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of lung metastases by the CD26/DPP4 inhibitor Vildagliptin in mice.
    Jang JH; Baerts L; Waumans Y; De Meester I; Yamada Y; Limani P; Gil-Bazo I; Weder W; Jungraithmayr W
    Clin Exp Metastasis; 2015 Oct; 32(7):677-87. PubMed ID: 26233333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vildagliptin, a CD26/DPP4 inhibitor, ameliorates bleomycin-induced pulmonary fibrosis via regulating the extracellular matrix.
    Liu Y; Qi Y
    Int Immunopharmacol; 2020 Oct; 87():106774. PubMed ID: 32731178
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CD26 costimulatory blockade improves lung allograft rejection and is associated with enhanced interleukin-10 expression.
    Yamada Y; Jang JH; De Meester I; Baerts L; Vliegen G; Inci I; Yoshino I; Weder W; Jungraithmayr W
    J Heart Lung Transplant; 2016 Apr; 35(4):508-17. PubMed ID: 26755203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DPP4 inhibition by sitagliptin attenuates LPS-induced lung injury in mice.
    Kawasaki T; Chen W; Htwe YM; Tatsumi K; Dudek SM
    Am J Physiol Lung Cell Mol Physiol; 2018 Nov; 315(5):L834-L845. PubMed ID: 30188745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional roles of CD26/DPP4 in lipopolysaccharide-induced lung injury.
    Sato S; Kawasaki T; Hatano R; Koyanagi Y; Takahashi Y; Ohnuma K; Morimoto C; Dudek SM; Tatsumi K; Suzuki T
    Am J Physiol Lung Cell Mol Physiol; 2024 May; 326(5):L562-L573. PubMed ID: 38469626
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl peptidase-4 inhibitor protects against non-alcoholic steatohepatitis in mice by targeting TRAIL receptor-mediated lipoapoptosis via modulating hepatic dipeptidyl peptidase-4 expression.
    Lee M; Shin E; Bae J; Cho Y; Lee JY; Lee YH; Lee BW; Kang ES; Cha BS
    Sci Rep; 2020 Nov; 10(1):19429. PubMed ID: 33173107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Caveolin-1, a binding protein of CD26, is essential for the anti-inflammatory effects of dipeptidyl peptidase-4 inhibitors on human and mouse macrophages.
    Hiromura M; Nohtomi K; Mori Y; Kataoka H; Sugano M; Ohnuma K; Kuwata H; Hirano T
    Biochem Biophys Res Commun; 2018 Jan; 495(1):223-229. PubMed ID: 29113797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPP4 inhibition mitigates ANG II-mediated kidney immune activation and injury in male mice.
    Nistala R; Meuth AI; Smith C; An J; Habibi J; Hayden MR; Johnson M; Aroor A; Whaley-Connell A; Sowers JR; McKarns SC; Bender SB
    Am J Physiol Renal Physiol; 2021 Mar; 320(3):F505-F517. PubMed ID: 33522410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of the dipeptidyl peptidase DPP4 (CD26) reveals IL-33-dependent eosinophil-mediated control of tumor growth.
    Hollande C; Boussier J; Ziai J; Nozawa T; Bondet V; Phung W; Lu B; Duffy D; Paradis V; Mallet V; Eberl G; Sandoval W; Schartner JM; Pol S; Barreira da Silva R; Albert ML
    Nat Immunol; 2019 Mar; 20(3):257-264. PubMed ID: 30778250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mechanism of sitagliptin inhibition of colorectal cancer cell lines' metastatic functionalities.
    Varela-Calviño R; Rodríguez-Quiroga M; Dias Carvalho P; Martins F; Serra-Roma A; Vázquez-Iglesias L; Páez de la Cadena M; Velho S; Cordero OJ
    IUBMB Life; 2021 May; 73(5):761-773. PubMed ID: 33615655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of dipeptidyl peptidase IV prevents high fat diet-induced liver cancer angiogenesis by downregulating chemokine ligand 2.
    Qin CJ; Zhao LH; Zhou X; Zhang HL; Wen W; Tang L; Zeng M; Wang MD; Fu GB; Huang S; Huang WJ; Yang Y; Bao ZJ; Zhou WP; Wang HY; Yan HX
    Cancer Lett; 2018 Apr; 420():26-37. PubMed ID: 29409972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.
    Zebedin-Brandl E; Themanns M; Kazemi Z; Nasrollahi-Shirazi S; Mussbacher M; Heyes E; Meissl K; Prchal-Murphy M; Strohmaier W; Krumpl G; Freissmuth M
    J Mol Med (Berl); 2020 Feb; 98(2):233-243. PubMed ID: 31872285
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Perspectives of CD26 Inhibitors in Imune-Mediated Diseases.
    Hu X; Wang X; Xue X
    Molecules; 2022 Jul; 27(14):. PubMed ID: 35889373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CD26 as a target against fibrous formation in chronic airway rejection lesions.
    Jungraithmayr W; Yamada Y; Haberecker M; Breuer E; Schuurmans M; Dubs L; Itani S; Janker F; Weder W; Schmitt-Opitz I; Jang JH
    Life Sci; 2021 Aug; 278():119496. PubMed ID: 33894269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26 Is Differentially Expressed throughout the Life Cycle of Infantile Hemangiomas and Characterizes the Proliferative Phase.
    Lorusso B; Nogara A; Fioretzaki R; Corradini E; Bove R; Roti G; Gherli A; Montanaro A; Monica G; Cavazzini F; Bonomini S; Graiani G; Silini EM; Gnetti L; Pilato FP; Cerasoli G; Quaini F; Lagrasta CAM
    Int J Mol Sci; 2024 Sep; 25(18):. PubMed ID: 39337249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Middle east respiratory syndrome corona virus spike glycoprotein suppresses macrophage responses via DPP4-mediated induction of IRAK-M and PPARγ.
    Al-Qahtani AA; Lyroni K; Aznaourova M; Tseliou M; Al-Anazi MR; Al-Ahdal MN; Alkahtani S; Sourvinos G; Tsatsanis C
    Oncotarget; 2017 Feb; 8(6):9053-9066. PubMed ID: 28118607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD26/DPP-4 inhibition recruits regenerative stem cells via stromal cell-derived factor-1 and beneficially influences ischaemia-reperfusion injury in mouse lung transplantation.
    Jungraithmayr W; De Meester I; Matheeussen V; Baerts L; Arni S; Weder W
    Eur J Cardiothorac Surg; 2012 May; 41(5):1166-73. PubMed ID: 22219460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.